Crossmark

Influence of the COVID-19 pandemic on the achievement of guideline targets for HbA1c, blood pressure, and LDL cholesterol in people with diabetes in Japan

Crossref DOI link: https://doi.org/10.1007/s13340-024-00715-8

Published Online: 2024-04-08

Published Print: 2024-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kuwajima, Shingo

Itoh, Takahito

Sato, Tatsuya

Ino, Shoya

Shibata, Satoru

Ohno, Kouhei

Hotta, Hiroyuki

Matsumoto, Tomoaki

Ooiwa, Hitoshi

Kubo, Hirofumi

Miki, Takayuki https://orcid.org/0000-0002-3104-4925
License Information

Text and Data Mining valid from 2024-04-08

Version of Record valid from 2024-04-08
More Information

Article History

Received: 22 August 2023

Accepted: 18 March 2024

First Online: 8 April 2024

Declarations

:

: TS received honoraria for educational lectures from Daiichi Sankyo Co., Ltd. TaM received honoraria for educational lectures from AstraZeneca K.K., Eli Lilly Japan K.K., Nippon Boehringer Ingerheim Co., Novartis Pharma K.K., Novo Nordisk Pharma, and Ono Pharmaceutical Co. All other authors declare that they have no conflict of interest.

: This study was conducted in strict adherence with the principles of the Declaration of Helsinki and was approved by the Clinical Investigation Ethics Committee of Oji General Hospital (approval no. OGH2020-12; approval date April 7, 2020).

: Informed consent was obtained by the opt-out method on the website of Oji General Hospital.

Document is current

Any future updates will be listed below